JPWO2019217933A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019217933A5 JPWO2019217933A5 JP2020562120A JP2020562120A JPWO2019217933A5 JP WO2019217933 A5 JPWO2019217933 A5 JP WO2019217933A5 JP 2020562120 A JP2020562120 A JP 2020562120A JP 2020562120 A JP2020562120 A JP 2020562120A JP WO2019217933 A5 JPWO2019217933 A5 JP WO2019217933A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- ocf
- alkoxy
- carboxy
- heterocyclyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024022691A JP2024056937A (ja) | 2018-05-10 | 2024-02-19 | Ｒａｓ腫瘍性タンパク質の阻害剤、その作製方法及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862669926P | 2018-05-10 | 2018-05-10 | |
| US62/669,926 | 2018-05-10 | ||
| PCT/US2019/031885 WO2019217933A1 (en) | 2018-05-10 | 2019-05-10 | Inhibitors of the ras oncoprotein, methods of making and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024022691A Division JP2024056937A (ja) | 2018-05-10 | 2024-02-19 | Ｒａｓ腫瘍性タンパク質の阻害剤、その作製方法及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021528368A JP2021528368A (ja) | 2021-10-21 |
| JPWO2019217933A5 true JPWO2019217933A5 (https=) | 2022-05-17 |
| JP2021528368A5 JP2021528368A5 (https=) | 2022-05-17 |
Family
ID=68467113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020562120A Pending JP2021528368A (ja) | 2018-05-10 | 2019-05-10 | Ｒａｓ腫瘍性タンパク質の阻害剤、その作製方法及びその使用方法 |
| JP2024022691A Pending JP2024056937A (ja) | 2018-05-10 | 2024-02-19 | Ｒａｓ腫瘍性タンパク質の阻害剤、その作製方法及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024022691A Pending JP2024056937A (ja) | 2018-05-10 | 2024-02-19 | Ｒａｓ腫瘍性タンパク質の阻害剤、その作製方法及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12582660B2 (https=) |
| EP (1) | EP3790541B1 (https=) |
| JP (2) | JP2021528368A (https=) |
| KR (1) | KR20210009331A (https=) |
| CN (1) | CN112312901B (https=) |
| AU (1) | AU2019265011B2 (https=) |
| CA (1) | CA3099148A1 (https=) |
| IL (1) | IL278596B2 (https=) |
| MX (1) | MX2020011991A (https=) |
| WO (1) | WO2019217933A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112312901B (zh) | 2018-05-10 | 2024-05-14 | 路易斯维尔大学研究基金会有限公司 | Ras癌蛋白抑制剂及其制备方法和使用方法 |
| IL299131A (en) | 2020-06-18 | 2023-02-01 | Revolution Medicines Inc | Methods for delaying, preventing and treating acquired resistance to RAS inhibitors |
| MX2023002248A (es) | 2020-09-03 | 2023-05-16 | Revolution Medicines Inc | Uso de inhibidores de sos1 para tratar neoplasias malignas con mutaciones de shp2. |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60233051A (ja) | 1984-05-04 | 1985-11-19 | Daicel Chem Ind Ltd | ２−クロル−５−ニトロベンゼンスルホンアミドの製造方法 |
| US4944796A (en) * | 1988-11-14 | 1990-07-31 | Ici Americas Inc. | Certain 2-(disubstituted amino) acetanilide herbicides |
| CN1145608C (zh) * | 1998-06-09 | 2004-04-14 | 诺特兰药品有限公司 | 作为镇咳剂的季铵化合物 |
| US20080139534A1 (en) | 2006-12-07 | 2008-06-12 | Xavier University Of Louisiana | Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis |
| US7951806B2 (en) * | 2007-07-25 | 2011-05-31 | Renascience Co., Ltd. | Plasminogen activator inhibitor-1 inhibitor |
| FR2925495B1 (fr) * | 2007-12-21 | 2010-09-10 | Pf Medicament | Derives dimeriques d'artemisinine et application en therapie anticancereuse |
| GB0808282D0 (en) | 2008-05-07 | 2008-06-11 | Medical Res Council | Compounds for use in stabilizing p53 mutants |
| CN101919842A (zh) | 2009-06-11 | 2010-12-22 | 复旦大学 | 一种苯丙噻吩衍生物在制备抗肿瘤药物中的应用 |
| US8557980B2 (en) | 2010-02-18 | 2013-10-15 | The Board Of Trustees Of The University Of Illinois | Methods for forming protected organoboronic acids |
| AU2011239537A1 (en) * | 2010-04-16 | 2012-11-15 | Curis, Inc. | Treatment of cancers having K-ras mutations |
| KR20120048223A (ko) | 2010-11-05 | 2012-05-15 | 주식회사 이큐스앤자루 | 2-페닐-4-[3-(치환된-설포닐)아닐리노]퀴나졸린 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 ｃ형 간염의 예방 또는 치료용 약학적 조성물 |
| GB201020397D0 (en) | 2010-12-02 | 2011-01-12 | Univ Nottingham | Compounds |
| EP2759533B1 (en) | 2011-09-22 | 2017-08-02 | Takeda Pharmaceutical Company Limited | Condensed heterocyclic compound |
| WO2014037726A1 (en) * | 2012-09-06 | 2014-03-13 | Verona Pharma Plc | Liquid pharmaceutical compositions |
| ES2491390B1 (es) * | 2013-02-04 | 2015-06-22 | Universidad Complutense De Madrid | Nuevos inhibidores de la enzima isoprenilcisteina carboximetiltransferasa (icmt) |
| EP2984088B1 (en) | 2013-04-12 | 2019-03-20 | Asana BioSciences, LLC | Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathways |
| US9181288B2 (en) | 2014-01-16 | 2015-11-10 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
| US20160168108A1 (en) * | 2014-12-16 | 2016-06-16 | Adt Pharmaceuticals, Inc. | Method of treating or preventing ras-mediated diseases |
| CA3017211A1 (en) | 2016-03-16 | 2017-09-21 | Endocyte, Inc. | Carbonic anhydrase ix inhibitor conjugates and uses thereof |
| CN112312901B (zh) | 2018-05-10 | 2024-05-14 | 路易斯维尔大学研究基金会有限公司 | Ras癌蛋白抑制剂及其制备方法和使用方法 |
-
2019
- 2019-05-10 CN CN201980038063.7A patent/CN112312901B/zh active Active
- 2019-05-10 US US17/053,057 patent/US12582660B2/en active Active
- 2019-05-10 MX MX2020011991A patent/MX2020011991A/es unknown
- 2019-05-10 IL IL278596A patent/IL278596B2/en unknown
- 2019-05-10 AU AU2019265011A patent/AU2019265011B2/en not_active Expired - Fee Related
- 2019-05-10 KR KR1020207035159A patent/KR20210009331A/ko not_active Ceased
- 2019-05-10 EP EP19800358.4A patent/EP3790541B1/en active Active
- 2019-05-10 WO PCT/US2019/031885 patent/WO2019217933A1/en not_active Ceased
- 2019-05-10 CA CA3099148A patent/CA3099148A1/en active Pending
- 2019-05-10 JP JP2020562120A patent/JP2021528368A/ja active Pending
-
2024
- 2024-02-19 JP JP2024022691A patent/JP2024056937A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020203246B2 (en) | Polymorphs of selinexor | |
| RU2449996C2 (ru) | СОЕДИНЕНИЯ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЗАИМОДЕЙСТВИЯ БЕЛКОВ Bcl С ПАРТНЕРАМИ СВЯЗЫВАНИЯ | |
| TW536401B (en) | A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain | |
| JP2012529486A5 (https=) | ||
| RU2672575C2 (ru) | Лечение рака головного мозга | |
| CA2440037A1 (en) | Benzimidazole derivatives for modulating the rage receptor | |
| JP2019515908A5 (https=) | ||
| JP2019505585A (ja) | ２−ブロモ−１−（３，３−ジニトロアゼチジン−１−イル）エタノンの静脈内投与のための組成物および方法 | |
| JP2010522714A (ja) | 新規な医薬組成物 | |
| EP2455081A1 (en) | S1P1 receptor agonists for use in the treatment of crohn's disease | |
| EP2455080A1 (en) | S1P1 receptor agonists for use in the treatment of multiple sclerosis | |
| JP2013231076A (ja) | ｍＴＯＲ阻害剤とＲａｆキナーゼ阻害剤を含む医薬組合せ剤 | |
| DE60033044T2 (de) | Zusammensetzung von morphin methansulphonat und chitosan zur nasalen verabreicherung | |
| JP2021528368A5 (https=) | ||
| NZ550174A (en) | Combinations comprising a vasculostatic compound such as vatalanib and epothilones, and pharmaceutical uses thereof | |
| DE69412662T2 (de) | Angiotensin II-Antagonisten zur Behandlung von viralen Erkrankungen | |
| CN1181819C (zh) | 使用五氟苯磺酰胺的综合疗法 | |
| JPWO2019217933A5 (https=) | ||
| JPWO2021093839A5 (https=) | ||
| CN105267214B (zh) | N-杂芳基苯胺类化合物作为制备抗肿瘤药物的应用 | |
| RU2020140423A (ru) | Ингибиторы онкопротеина ras, способы их получения и способы их применения | |
| US20160143914A1 (en) | Nanoparticles for Encapsulation and Delivery of Bioactive Compounds and Compositions Thereof | |
| JPS59205318A (ja) | コデルゴクリンとカルシウム拮抗剤からなる製剤 | |
| EP1623741A2 (en) | Cannabinoid receptor ligands for hair growth modulation | |
| JP2010526073A (ja) | 癌または前癌性症状およびその他の症状の治療のためのジヒドロピリジン誘導体 |